The main market opportunities include enhancing pharmaceutical manufacturing quality through advanced cGMP training, reducing violations, and improving operational efficiency by adhering to FDA ...
Morning Overview on MSN
FDA moves to fast-track psychedelic drug reviews after Trump directive
The FDA announced on April 24, 2026, that it has granted a new class of accelerated review vouchers to three psychedelic drug ...
OpenAI Has a New AI Model Built for Biology and Science ...
The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...
A sit-down with Professor Eric Xing, the president of the UAE’s Mohamed bin Zayed University of Artificial Intelligence.
Insilico Medicine has expanded its Science MMAI Gym, a large-scale training and benchmarking platform for artificial ...
MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of ...
The global biosimulation market is projected to surge from USD 6.15 billion in 2026 to USD 28.50 billion by 2036, reflecting a CAGR of 16.5%, according to the report "Biosimulation Market - Global ...
Discover how medical 3D printing creates patient-specific devices and custom prosthetics. Read our guide to clinical ...
Novo Nordisk (NVO) stock surged 2.8% after revealing an OpenAI partnership to integrate AI in drug discovery, manufacturing, ...
Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology, have announced an expanded collaboration with the Barcelona Supercomputing Center - Centro Nacional de ...
Ferris State University received a $1.92 million grant from the U.S. Department of Commerce's National Institute of Standards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results